NCI | Technology Transfer

Anti-Mesothelin Antibodies Useful for Immunological Assays

Read more about Anti-Mesothelin Antibodies Useful for Immunological Assays

European Patent
06759723.7
Filed on 2006-05-11

Anti-Mesothelin Antibodies Useful for Immunological Assays

Read more about Anti-Mesothelin Antibodies Useful for Immunological Assays

Canada
2607305
Filed on 2006-05-11

Anti-Mesothelin Antibodies Useful for Immunological Assays

Read more about Anti-Mesothelin Antibodies Useful for Immunological Assays

Australia
2006247565
Filed on 2006-05-11

ZAP-70 EXPRESSION AS A MARKER FOR CHRONIC LYMPHOCYTIC LEUKEMIA / SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL)

Read more about ZAP-70 EXPRESSION AS A MARKER FOR CHRONIC LYMPHOCYTIC LEUKEMIA / SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL)

US Patent 7,981,610
Filed on 2007-12-12

METHODS AND COMPOSITIONS FOR TRANSFORMING DENDRITIC CELLS AND ACTIVATING T CELLS

Read more about METHODS AND COMPOSITIONS FOR TRANSFORMING DENDRITIC CELLS AND ACTIVATING T CELLS

US Application 11/978,019
Filed on 2007-10-25

FITNESS ASSAY AND ASSOCIATED METHODS

Read more about FITNESS ASSAY AND ASSOCIATED METHODS

US Patent 8,597,876
Filed on 2007-10-11

North-2'-Dexoxy-Methanocarbathymidine as Antiviral Agent for Treatment of Kaposi's Sarcoma-Associated Herpes Virus

Read more about North-2'-Dexoxy-Methanocarbathymidine as Antiviral Agent for Treatment of Kaposi's Sarcoma-Associated Herpes Virus

US Application 11/918,510
Filed on 2007-10-15

Methods and Compositions For Producing An Enhanced Immune Response To A Human Papilloma Virus Immunogen

Read more about Methods and Compositions For Producing An Enhanced Immune Response To A Human Papilloma Virus Immunogen

Canada
2604909
Filed on 2006-04-11

T-cell Binding Epitope From The Human Papillomaviurs Type 16 E2 Region That Induces Significan CD8+ Cell Response And CTL Lysis Activity Both Bound To HLA.A2 And When Pulsed As A Peptide.

Read more about T-cell Binding Epitope From The Human Papillomaviurs Type 16 E2 Region That Induces Significan CD8+ Cell Response And CTL Lysis Activity Both Bound To HLA.A2 And When Pulsed As A Peptide.

Australia
2006236905
Filed on 2006-04-11

METHODS AND COMPOSITIONS FOR PRODUCING AN ENHANCED IMMUNE RESPONSE TO A HUMAN PAPILLOMAVIRUS IMMUNOGEN

Read more about METHODS AND COMPOSITIONS FOR PRODUCING AN ENHANCED IMMUNE RESPONSE TO A HUMAN PAPILLOMAVIRUS IMMUNOGEN

European Patent
06749659.6
Filed on 2006-04-11

Subscribe to NCI